Free Access
Med Sci (Paris)
Volume 29, Number 10, Octobre 2013
Page(s) 923 - 925
Section Forum
Published online 18 October 2013
  1. Jordan B. Thérapie génique, espoir ou illusion ? Paris : Odile Jacob, 2007. [Google Scholar]
  2. Wilson JM. Gendicine: the first commercial gene therapy product. Hum Gene Ther 2005 ; 16 : 1014–1015. [CrossRef] [PubMed] [Google Scholar]
  3. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000 ; 288 : 669–672. [CrossRef] [PubMed] [Google Scholar]
  4. Ponder KP. Merry Christmas for patients with hemophilia B. N Engl J Med 2011 ; 365 : 2424–2425. [CrossRef] [PubMed] [Google Scholar]
  5. Nathwani AC, Tuddenham EG, Rangarajan S, et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011 ; 365 : 2357–2365. [CrossRef] [PubMed] [Google Scholar]
  6. Kastelein JJ, Ross CJ, Hayden MR. From mutation identification to therapy: discovery and origins of the first approved gene therapy in the Western world. Hum Gene Ther 2013 ; 24 : 472–478. [CrossRef] [PubMed] [Google Scholar]
  7. Colella P, Auricchio A. Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients. Hum Gene Ther 2012 ; 23 : 796–807. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.